Calico Life Sciences is a biotechnology company founded in 2013 by Google (Alphabet Inc.) to address aging and extend human healthspan. Headquartered in San Francisco, California, Calico conducts basic and applied research on aging biology and develops therapeutic interventions targeting age-related diseases. Operating as an Alphabet subsidiary, the company leverages Google's computational resources and long-term funding horizon while maintaining scientific independence. Calico publishes peer-reviewed research and partners with established pharmaceutical companies like AbbVie to advance drug candidates into clinical development. The company represents Alphabet's moonshot approach to healthcare, tackling aging as a root cause of multiple diseases rather than treating conditions individually.
Calico operates as a research-focused organization with a mission-driven culture centered on extending human health and lifespan. The company emphasizes scientific rigor and attracting top-tier researchers from academia and industry. Supported by Alphabet's resources and long-term commitment, Calico maintains a collaborative environment where basic science and translational medicine inform the drug discovery pipeline. The organization balances the boldness of moonshot thinking with disciplined scientific methodology.
29 open now, 29 first appeared in the last 30d.